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Introduction
In any patient with a first attack of posterior uveitis, it is
important to differentiate whether the underlying cause is
infective or non-infective in nature. However, when patients
with a history of non-infective posterior inflammation
present with recurrent symptoms of a flare-up, there is natu-
rally a much lower suspicion of an infective aetiology and
immunosuppression is usually commenced for the ‘flare-up’.
We present a case of infective posterior uveitis due to a rare
pathogen occurring in a patient with a known history of
sarcoid uveitis which was initially misdiagnosed and treated
as a ‘flare-up’.
Case report
A 60-year-old male farmer with previous history of bilateral
anterior and posterior uveitis, secondary to sarcoidosis, pre-
sented with new symptoms of visual blurring in the left eye,
headaches and dizziness. Prior to this episode, he had been
under regular follow-up for flare-ups of posterior uveitis
affecting one or both eyes over a 10-year period. His epi-
sodes of inflammatory flare-ups have typically responded
well to short courses of systemic corticosteroid therapy. The
most recent flare-up, prior to this current episode 4 months
earlier, was successfully treated with oral prednisolone with
recovery to visual acuities of 6/6 right and 6/6 left.
On this presentation, his visual acuities were 6/6 right and
6/9 left. Colour vision was normal in the right eye (15/17), but
was reduced in the left eye to 1/17 (Ishihara test). Both anterior
segments were clear, without any signs of anterior uveitis.
Posterior segment examination showed no signs of vitritis in
either eye, but in the left eye there was a preexisting epiretinal
membrane and new optic disc swelling (Fig. 1). Systemic
examination was normal and he was apyrexial.
At this stage, several possibilities were being considered,
including inflammatory flare-up of ocular sarcodosis with
optic nerve involvement, neurosarcoid, or infiltrative or com-
pressive optic neuropathy. CT and MRI scans of the head and
brain showed no radiological signs of inflammatory or space-
occupying lesions in the left optic nerve and chiasma. As there
was no evidence to suggest an infective cause at that stage, he
was commenced on 60 mg/day of oral prednisolone.
Initially, his left eye improved slightly to 6/6, but reduced
colour vision persisted and headaches worsened, accompa-
nied by transient confusion and an episode of slurred speech.
The prednisolone dosage was briskly tapered and he was
admitted into a hospital for further investigations. Because
of the poor response to corticosteroid therapy and the
appearance of new neurological symptoms, other neurolog-
ical conditions were being considered, including tuberculous
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meningitis, fungal meningitis, prion disease and neurosarcoi-
dosis. He was still apyrexial and initial blood investigations
and infection screen (including VDRL, HIV and AFB) were
all normal.
After several unsuccessful attempts at lumbar puncture, a
CT-guided lumbar puncture yielded a sufficient sample
which, on culture, grew a cryptococcal-like species which
stains positive with India ink (silhouette indicating the pres-
ence of the polysaccharide capsule of Cryptococcus species;
Fig. 2). The organism in this sample was confirmed as
Cryptococcus neoformans using the latex agglutination test,
which is superior to the India ink technique and is specific
for the polysaccharide antigens of the encapsulated neofor-
mans species [1].
The patient was thus diagnosed with meningoencephalitis
secondary to C. neoformans infection and commenced on
two weeks of intravenous antifungal therapy of amphotericin
4 mg/kg once a day and flucytosine 25 mg/kg four times a day,
followed later by oral fluconazole 400 mg OD for the next
twelve months.
The patient’s headaches improved completely after anti-
fungal therapy, and visual acuity was measured at R 6/9 and
L 6/9, Ishihara plate testing R15/17 and L 2/17. The left
optic disc swelling also resolved (Fig. 3).
Discussion
Cryptococcal infections (crypotococcoses) are most com-
monly caused by C. neoformans. This species is almost
always synonymous with immunosuppression, particularly
HIV infection. It has also been described with organ trans-
plantation, malignancy, sarcoidosis, liver failure and even
diabetes mellitus [2–4]. However, in a recent Canadian
study, MacDougall et al. [5] reported the occurrence of
infection in immunocompetent individuals by the Crypto-
coccus gatii species.
Asymptomatic pulmonary infection by Cryptococcus is
common, even in the immunocompetent; usually, it is only
in the immunocompromised that meningeal involvement
occurs. Routine blood tests may be normal, making the
diagnosis more difficult to confirm. Unfortunately, ‘cure’
can often prove difficult, with patients suffering from re-
lapse of infection [6].
Due to our patient’s occupation as a farmer, he was fre-
quently in contact with avian excreta, a potential source of
infection by Cryptococcus species [7]. Furthermore, he was
immunosuppressed, not only through receiving recurrent sys-
temic corticosteroids but also through having sarcoidosis per
se, which may have made him additionally vulnerable to the
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cryptococcal infection. There have been several reports of a
specific association between cryptococcal infection and sar-
coidosis [8–10]. Botha and Wessels [10] postulated that this
susceptibility is either due to immunosuppression from steroid
use or exclusively to impaired T cell-mediated immunity as a
result of sarcoidosis in patients not treated with steroids.
Impaired T cell-mediated immunity in such patients could be
due to the sequestration of T cells within organs affected by
sarcoid, such as the lung.
Conclusion
The diagnostic challenge of differentiating an infectious
cause from a non-infectious (inflammatory) cause is a com-
mon one when a patient presents for the first time with
posterior uveitis. Non-infectious causes are much more
common, and once confirmed, the patients usually respond
well to immunosuppression with steroids or steroid-sparing
agents. This case illustrates a rare and challenging scenario
in which a patient presents with an infective cause of
posterior uveitis but has had multiple episodes of non-
infectious flare-ups of posterior uveitis which responded
well to immunosuppression previously. Therefore, less com-
mon, infectious causes of active posterior uveitis need to be
considered not only when investigating patients with their
first presentation but also when they present with ‘flare-ups’
despite a previous history of non-infectious flare-ups as they
can be immunocompromised from their therapy or from the
underlying inflammatory conditions.
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